2. Expectation Management
• I am not a Clinical Trials Expert
• I am a fan…. for the work Foundry Health with Brock, Josh and the
team. They are disruptors in an industry that needs massive
disruption.
• I built a professional services firm that focuses on solving big ugly
problems. We have several healthcare customers and chose to solve
the biggest and ugliest problem in Healthcare – Interoperability with a
managed services offering called HealthLX.
• With that…. I am about to bore you.
10/14/17 HealthLX Confidential 2
3. Data-Integration Landscape … today.
• Tools – Online (Redox) or On-Prem (Intersystems, Pilotfish, etc.), Custom coding still
prevails…
• Data Exchanges (System-centric)
• HIEs are largely failing because they’re incentives are not ‘Patient-centric’
• EHRs are siloed but claiming broad capabilities
• ACOs require Payer-Provider integration beyond traditional use cases of shared PHI interchange
• Evolution happening with new repeatable data design patterns as a managed service.
• ‘Dataflow’ Standards continue to be shifting (FHIR, Commonwell, Others); Process flow
standards are slower to adoption.
• Blockchain movement is absolutely gaining momentum
• Legacy will not disappear for a long….. Time. à Poor Governance
• Externalizing Reporting for compliance or contract reasons requires data agility from
source systems.
10/14/17 HealthLX Confidential 3
4. A few key realities…
10/14/17 HealthLX Confidential 4
Interoperability and data exchange are driving technology
buying decisions at 36% of healthcare organizations
~ Survey by TechTarget
The International Committee of Medical Journal
Editors (ICMJE) believes that there is an ethical
obligation to responsibly share data generated by
interventional clinical trials because participants have
put themselves at risk. In a growing consensus, many
funders around the world—foundations, government
agencies, and industry—now mandate data
sharing. ~ ICMJE
Obtaining an individual’s consent is strictly tied to the Helsinki
declaration7,8(http://www.wma.net/en/30publications/10poli
cies/b3/index.html), which provides the good practices that
should follow any stakeholder conducting a clinical trial.
Point 26 of the Declaration states that each participant should
be informed of the aim, methods, sources of funding, conflict
of interests, affiliations of the researchers, anticipated
benefits and risks and post-study provisions, and these
conditions must be met to obtain freely-given informed
consent. Among those and of major importance, informed
consent should be documented by a signed and dated written
consent, which is particularly meaningful with Blockchain
technology. ~ F1000 Research
Don’t worry about people stealing your ideas. If
your ideas are any good, you’ll have to ram
them down people’s throats ~ Howard Aiken
19. 10/14/17 HealthLX Confidential 19
Partner HIT solution as a Platform - Integrations
19
Simple
ADT
Complex
ADT
CCD PDF
Import
CCD Data
Import
CCD PDF
Import
Note
Transfer
Task
Transfer
In-Home
Monitor
Interpreta
Integration
TruCare
Platform
300+ Web Services
TruCare Linx
TruCare Linx Benefits
§ Advanced workflow configuration
§ Data governance
§ Upgrade maintenance
EMRs Home
Services
IVR Systems
Member
Portals
Mobile Apps Provider
Portals
HIE In Home
Monitoring
RX Apps
Governance
Error
Remediation
Data Cleansing
Message
Enrichment
Simple
ADT
CCD PDF
Import
CCD PDF
Export
Note
Transfer
Task
Transfer
Custom
Connector
Development
Production
Roadmap
Legend:CRM
Integration
Complex
ADT